Allarity Therapeutics, Inc. 10-Q filing
Filed 2025-11-14 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001437749-25-035003
- Form type
- 10-Q
- CIK
- 0001860657
- Primary document
- https://www.sec.gov/Archives/edgar/data/1860657/000143774925035003/allr20250930_10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Allarity Therapeutics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-9.7M | - | - |
| Net Income | $-7.9M | - | - |
| Eps Basic | -0.57 | - | - |
| Cash And Equivalents | $16.9M | - | - |
| Total Assets | $20.8M | - | - |
| Total Liabilities | $8.8M | - | - |
| Shareholders Equity | $12.0M | - | - |
| Operating Cash Flow | $-11.6M | - | - |